Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $211,862 - $275,185
-8,108 Reduced 12.16%
58,585 $1.69 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $16,526 - $19,317
515 Added 0.78%
66,693 $2.21 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $15,206 - $17,593
-421 Reduced 0.63%
66,178 $2.43 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $388,464 - $505,723
-9,862 Reduced 12.9%
66,599 $2.72 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $427,186 - $557,644
10,232 Added 15.45%
76,461 $3.92 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $11,596 - $14,156
265 Added 0.4%
66,229 $2.9 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $10,655 - $12,633
-229 Reduced 0.35%
65,964 $3.46 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $8,784 - $10,884
192 Added 0.29%
66,193 $3.43 Million
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $205,484 - $304,596
4,973 Added 8.15%
66,001 $3.9 Million
Q3 2021

Nov 16, 2021

BUY
$39.25 - $50.42 $2,433 - $3,126
62 Added 0.1%
61,028 $2.63 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $92,145 - $104,384
2,566 Added 4.39%
60,966 $2.39 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $1.96 Million - $2.21 Million
58,400 New
58,400 $2.12 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Clayton Partners LLC Portfolio

Follow Clayton Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clayton Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clayton Partners LLC with notifications on news.